MediciNova, Inc. - MNOV
About Gravity Analytica
Recent News
- 12.01.2025 - Message from the CEO to MediciNova Shareholders
- 11.18.2025 - MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
- 11.06.2025 - MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
- 10.30.2025 - MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
- 10.06.2025 - MediciNova to Present at the LD Micro Main Event XIX Investor Conference
- 10.06.2025 - MediciNova to Present at the LD Micro Main Event XIX Investor Conference
- 10.06.2025 - MediciNova to Present at the LD Micro Main Event XIX Investor Conference
- 09.22.2025 - MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
- 09.22.2025 - MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
- 09.22.2025 - MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)